Best Rising Stocks To Buy Right Now

Margins matter. The more CONMED (Nasdaq: CNMD  ) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders. Healthy margins often separate pretenders from the best stocks in the market. That's why we check up on margins at least once a quarter in this series. I'm looking for the absolute numbers, so I can compare them to current and potential competitors, and any trend that may tell me how strong CONMED's competitive position could be.

Here's the current margin snapshot for CONMED over the trailing 12 months: Gross margin is 54.5%, while operating margin is 10.7% and net margin is 5.4%.

Unfortunately, a look at the most recent numbers doesn't tell us much about where CONMED has been, or where it's going. A company with rising gross and operating margins often fuels its growth by increasing demand for its products. If it sells more units while keeping costs in check, its profitability increases. Conversely, a company with gross margins that inch downward over time is often losing out to competition, and possibly engaging in a race to the bottom on prices. If it can't make up for this problem by cutting costs -- and most companies can't -- then both the business and its shares face a decidedly bleak outlook.

Best Rising Stocks To Buy Right Now: Energy Select Sector SPDR Fund (XLE)

Energy Select Sector SPDR Fund (the Fund) seeks to provide investment results that correspond to the price and yield performance of the Energy Select Sector of the S&P 500 Index (the Index). The Index includes companies that primarily develop and produce crude oil and natural gas, and provide drilling and other energy-related services.

The Fund utilizes a passive or indexing investment approach to invest in a portfolio of stocks that seek to replicate the Index. The Fund�� investment advisor is SSgA Funds Management, Inc.

Advisors' Opinion:

• [By Craig Jones]

  © 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

    Most Popular Warren Buffett Reveals Quarterly Portfolio Changes As B
• [By Tom Aspray]

  With the recent decline in many of the high-flying biotechnology stocks, the PowerShares QQQ Trust (QQQ) is up 3.8%. Those who have been in either the Select Sector SPDR Energy (XLE) or the SPDR Dow Industrials (DIA) are pretty much flat for the year. This illustrates the importance of sector selection, and I have found relative performance to be the best tool. Using this approach to diversify your 401k in different sectors has shown to work quite well. (Learn to Drive Your Own 401k).

• [By Claudia Assis]

  The SPDR Energy Select Sector (XLE) , an exchange-traded fund focused on energy names, rose 0.6%.

Best Rising Stocks To Buy Right Now: Target Corporation(TGT)

Target Corporation operates general merchandise stores in the United States. The company offers household essentials, including pharmacy, beauty, personal care, baby care, cleaning, and paper products; hardlines comprising music, movies, books, computer software, sporting goods, and toys, as well as electronics that comprise video game hardware and software; apparel and accessories consisting of apparel for women, men, boys, girls, toddlers, infants, and newborns; and intimate apparel, jewelry, accessories, and shoes. It also provides food and pet supplies, including dry grocery, dairy, frozen food, beverages, candy, snacks, deli, bakery, meat, produce, and pet supplies; and home furnishings and d�or, such as furniture, lighting, kitchenware, small appliances, home d�or, bed and bath, home improvement, and automotive products, as well as seasonal merchandise, which include patio furniture and holiday d�or. The company sells its merchandise products under private-labe l and exclusive licensed brands. In addition, it provides in-store amenities. As of January 28, 2012, Target Corporation operated 1,763 stores in 49 states and the District of Columbia under Target and SuperTarget names. Further, it offers general merchandise through its Website, Target.com. The company distributes its merchandise through a network of distribution centers, as well as third parties and direct shipping from vendors. Additionally, it offers credit to guests through its branded proprietary credit cards, the Target Visa Credit Card and the Target Credit Card, as well as through its branded proprietary Target Debit Card. Target Corporation was founded in 1902 and is headquartered in Minneapolis, Minnesota.

Advisors' Opinion:

• [By Daniela Pylypczak]

  On Monday, retail giant Target (TGT) announced that its stores will be open on Thanksgiving day, giving shoppers early access to its Black Friday deals.

  Beginning at 8:00 pm on Thanksgiving day, Target shoppers will have access to the store’s doorbuster deals, which will take place in store and online from Thursday November 28 to Saturday November 30. Some of Target’s doorbuster deals include Apple iPad Minis for only $299 and the new iPad Air for $479.

  Commenting on Target’s Thanksgiving Day plans, executive vice president Kathee Tesija noted “For both our guests and team members, Black Friday is an exciting event that officially marks the beginning of the holiday shopping season. By offering advance access to deals at Target.com and opening our stores earlier, we are making it easier for guests to build a Black Friday ritual that works for them.�No matter where or when they choose to shop at Target, guests will be able to kick off their holiday shopping with deep discounts on a wide variety of the season�� most popular items.”

  Target shares inched 0.88% higher during Monday’s session. Year-to-date, the stock is up 10.69%.

• [By Rick Munarriz]

  Sanchez's time with the New York Jets may be coming to a close. Clips of last season's iconic play where the rear end of his own lineman caused a Sanchez fumble will haunt him until he gets another chance at redemption. A change of scenery may be necessary. Doesn't Johnson deserve another shot at redemption too? His success at Target (NYSE: TGT  ) at a time when it still wasn't socially acceptable to go cheap-chic and his legendary arrival at Apple (NASDAQ: AAPL  ) just as the consumer tech company was breaking into retail weren't flukes.�

• [By Brian Shaw]

  Amazon.com (NASDAQ: AMZN  ) �has plenty of opportunity to continue growing revenue at double-digit rates for the foreseeable future. However, it is important to acknowledge the significant challenges that exist in Amazon.com's pursuit of further market share gains from established retailers such as Wal-Mart (NYSE: WMT  ) and Target (NYSE: TGT  ) . Profitability pressures have forced Amazon.com to consider price increase to its wildly popular Prime service, and this could be the first of many challenges facing the company in the near future.

10 Best Oil Service Stocks To Buy For 2015: Amgen Inc.(AMGN)

Amgen Inc., a biotechnology medicines company, discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular biology for grievous illnesses primarily in the United States, Europe, and Canada. The company markets recombinant protein therapeutics in supportive cancer care, nephrology, and inflammation. Its principal products include Aranesp and EPOGEN erythropoietic-stimulating agents that stimulate the production of red blood cells; Neulasta and NEUPOGEN to stimulate the production of neutrophils, which is a type of white blood cell that helps the body to fight infections; and Enbrel, an inhibitor of tumor necrosis factor that plays a role in the body?s response to inflammatory diseases. The company also markets other products comprising Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin (TPO) receptor agonist that mimics endogenous TPO, the primary driver of platelet production. In addition, it provides Denosumab, a human monoclonal antibody that targets RANKL, an essential regulator of osteoclasts. Further, the company offers product candidates in mid-to-late stage development in a variety of therapeutic areas, including oncology, hematology, inflammation, bone, nephrology, cardiovascular, and general medicine consisting of neurology. It markets its products to healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies; consumers; and wholesale distributors of pharmaceutical products. The company has various collaborative arrangements with Pfizer Inc.; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Daiichi Sankyo Company, Limited; Array BioPharma Inc.; Kyowa Hakko Kirin Co. Ltd.; and Cytokinetics, Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.

Advisors' Opinion:

• [By Keith Speights]

  When it comes to biotechs, Amgen (NASDAQ: AMGN  ) qualifies for the senior citizen discount. The company, founded way back in 1980, ranks as one of the pioneers of the industry.

• [By Johanna Bennett]

  In a note published today, Goldman Sachs analysts Robert Boroujerdi, John Marshall, Michael Chanin and Krag Gregory say not much gfear�has been�priced into put options for either the S&P 500 or stocks with higher exposure to government spending. As a result, they suggest one of the following hedging strategies:

  Buy the optimal SPX puts to hedge a 5% down-move: Buying a November 1650 put on the S&P 500 index costs 1.2% and Goldman estimates a 2.7-to-1 payout if the index falls 5% by mid-October. Beware of government exposure: The firm tracks a basket of more than 100 companies that derive at least 20% of their revenue from the government. Though the list includes defense contractors and tech giant, more than half of the names are health-care companies, including Amgen (AMGN), HCA (HCA) and UnitedHealth Group (UNH). Buy puts on stocks with high government exposure: November puts on government-exposed names cost 2.4% on average (5% out of the money strike)
• [By Dan Carroll]

  Amgen on the acquisition trail
  Big biotech superstar Amgen (NASDAQ: AMGN  ) didn't have the best week in biotech, but it still made investors happy, as shares gained nearly 5% over the past five days. Amgen's hardly the kind of boom-or-bust stock that exemplifies this risk-fraught sector, but even this relatively stable pick can make waves. It's rumored to be one of the contenders looking to acquire fellow biotech star stock Onyx Pharmaceuticals (NASDAQ: ONXX  ) , according to sources in a report from Reuters released this week.

Best Rising Stocks To Buy Right Now: Petroleo Brasileiro S.A.- Petrobras(PBR)

Petroleo Brasileiro S.A. primarily engages in oil and natural gas exploration and production, refining, trade, and transportation businesses. The company?s Exploration and Production segment involves in the exploration, production, development, and production of oil, liquefied natural gas (LNG), and natural gas in Brazil. This segment supplies its products to the refineries in Brazil, as well as sells surplus petroleum and byproducts in domestic and foreign markets. Its Supply segment engages in the refining, logistics, transportation, and trade of oil and oil products; export of ethanol; and extraction and processing of schist, as well as holds interests in companies of the petrochemical sector in Brazil. The Gas and Energy segment involves in the transportation and trade of natural gas produced in or imported into Brazil; transportation and trade of LNG; and generation and trade of electric power. In addition, the segment has interests in natural gas transportation and d istribution companies; and thermoelectric power stations in Brazil, as well engages in fertilizer business. The Distribution segment distributes oil products, ethanol, and compressed natural gas in Brazil. The International segment involves in the exploration and production of oil and gas, as well as in supplying, gas and energy, and distribution operations in the Americas, Africa, Europe, and Asia. Further, the company involves in biofuel production business. Petroleo Brasileiro was founded in 1953 and is based in Rio de Janeiro, Brazil.

Advisors' Opinion:

• [By Sarfaraz A. Khan]

  The Brazilian energy giant Petroleo Brasileiro S.A (PBR), more commonly known as Petrobras, has been eyeing a turnaround but so far, it has fallen short of expectations. It managed to deliver a decent performance in its last quarter, but its ADR has fallen by 21.45% this year. The company is controlled by the Brazilian government through its 63% voting power. Petrobras has struggled with profitability because the business has been used as a tool to curb inflation. The company is eyeing an uptake in production in H2-2013, but I believe that, for now, investors should avoid this stock.

• [By Associated Press]

  Biden will be giving a speech in Rio de Janeiro on Wednesday and then pay a visit to state-run oil company Petrobras (NYSE: PBR  ) .

  Biden will also visit a slum while in Rio and on Friday meet with Brazil's President Dilma Rousseff, helping pave the way for her expected state visit to Washington later this year.

Best Rising Stocks To Buy Right Now: Parametric Technology Corporation(PMTC)

Parametric Technology Corporation develops, markets, and supports product lifecycle management (PLM) software solutions and services that help companies design products, manage product information, and enhance product development processes worldwide. Its PLM solutions comprise Windchill, an Internet-based content and process management solution for managing data and relationships, processes, and publications; Arbortext, an enterprise solution to manage complex information assets that enhance their customer support and service center information delivery processes; Creo View, which enables enterprise-wide visualization, verification, annotation, and automated comparison of various product development data formats; and Integrity that coordinates and manages various activities and artifacts associated with developing software-intensive products. The company?s desktop solutions include Creo Parametric, a family of three-dimensional product design solutions based on a parametr ic, feature-based solid modeler that enables changes made during the design process to be associatively updated throughout the design; Creo Elements/Direct, a family of computer aided design and collaboration software used for customers to meet short design cycles and to create product designs; Mathcad, an engineering calculation software solution, which combines a computational engine, accessed through conventional math notation, and with a full-featured word processor and graphing tools; and Arbortext to help customers improve documentation accuracy, speed time to market, reduce translation requirements, and lower publishing costs. In addition, it provides consulting, implementation, training, maintenance, and computer-based training products. Parametric Technology sells its products and services through direct sales force and third-party resellers and other strategic partners. The company was founded in 1985 and is headquartered in Needham, Massachusetts.

Advisors' Opinion:

• [By Markus Aarnio]

  Autodesk's competitors include Adobe Systems (ADBE), Dassault Systemes SA (DASTY.PK), and Parametric Technology Corporation (PMTC). Here is a table comparing these companies.

Best Rising Stocks To Buy Right Now: SS&C Technologies Holdings Inc.(SSNC)

SS&C Technologies Holdings, Inc. provides software products and software-enabled services to financial services providers primarily in the United States, Canada, Europe, the Asia Pacific, and Japan. Its software products and services allows its clients to automate and integrate front-office functions, such as trading and modeling; middle-office functions, including portfolio management and reporting; and back-office functions comprising accounting, performance measurement, reconciliation, reporting, processing, and clearing. The company?s products and services comprise management/accounting, real-time trading systems, treasury operations, financial modeling, loan management/accounting, property management, money market processing, and training products. Its software-enabled services consist of financial data acquisition, transformation, and delivery services; and business process outsourcing investment accounting and investment operations, hosting of its application softw are, automated workflow integration, automated quality control mechanisms, and interface and connectivity services. The company also offers on- and offshore fund administration services; outsourced administration services and software; real-time trade matching utility and delivery instruction database; securities data services; and broker-neutral and platform-neutral connectivity services. It serves institutional asset management, alternative investment management, and financial institutions vertical markets, as well as commercial lenders, corporate treasury groups, insurance and pension funds, municipal finance groups, and real estate property managers. The company was formerly known as Sunshine Acquisition Corporation and changed its name to SS&C Technologies Holdings, Inc. in June 2007. SS&C Technologies Holdings, Inc. was founded in 1986 and is headquartered in Windsor, Connecticut.

Advisors' Opinion:

• [By Evan Niu, CFA]

  What: Shares of SS&C Technologies (NASDAQ: SSNC  ) have skyrocketed by as much as 10% today after the company posted record first-quarter results.

Best Rising Stocks To Buy Right Now: Lennar Corp.(LEN)

The third largest U.S. homebuilder by revenue reported exceptional Q3 results, as its earnings more than quadrupled, primarily as a result of an increase in new-home demand. The reported net income of 40c was well ahead of last year's 11c, and the forecasted 28c.

According to the company's CEO, Stuart Miller, "The homebuilding business is beginning to revert to normal, and that's a positive for the U.S. economy in general, which is in turn good for sustained recovery in the housing market. Overall demand has been improving and we've seen a consistent sales pace at improving prices."

LEN's contract backlog, which is an indicator of future sales, rose by a whopping 79% on a YoY basis. Its average selling price of delivered homes also increased to $258,000 from last year's $247,000.

Advisors' Opinion:

• [By Bob Ciura]

  Therefore, it seems as though Americans are returning to the labor force, firming their financial positions, and buying homes. This has been evident in the earnings reports released so far in 2013 from the home building industry leaders, including PulteGroup (NYSE: PHM  ) , Lennar (NYSE: LEN  ) , and Toll Brothers (NYSE: TOL  ) .

• [By Lu Wang]

  Lennar (LEN), the third-largest U.S. homebuilder by revenue, rose 4.3 percent to $36.01 after fiscal third-quarter earnings topped analysts��estimates, driven by higher sales and home prices.

• [By maarnio]

  Beazer Homes��competitors include KB Home (KBH), Lennar (LEN), and PulteGroup (PHM). Here is a table comparing these companies.

  Company

Best Rising Stocks To Buy Right Now: Arris Group Inc(ARRS)

Arris Group, Inc. develops, manufactures, and supplies telephony, data, video, construction, rebuild, and maintenance equipment for the broadband communications industry worldwide. The company operates in three segments: Broadband Communications Systems (BCS); Access, Transport, and Supplies (ATS); and Media and Communications Systems (MCS). The BCS segment provides VoIP and high speed data products, including CMTS edge routers, 2-line residential EMTA, multi-line EMTA for residential and commercial services, wireless gateway, and high speed data cable modems; video/IP products comprising CMTS edge routers, broadband and universal EdgeQAM, and whole home gateway and media players; and video processing products, such as switched digital video systems, digital video encoders, transcoders, transraters, and statistical multiplexers. The ATS segment offers hybrid fiber-coaxial plant equipment products comprising headend and hub products, optical transmitters, optical amplifiers , optical repeaters, optical nodes, WiFi access points, ePON optical network units and line terminals, RF over glass optical network units, and radio frequency amplifiers; and infrastructure products for fiber optic or coaxial networks, which include cable and strand, vaults, conduit, drop materials, tools, connectors, and test equipment. The MCS segment provides media, delivery, and monetization platform products, such as video on demand management and distribution, and linear and advanced advertising; operations management systems comprising network and service assurance, and mobile workforce management; and fixed mobile convergence platform products, such as mobility application servers for continuity of services in wireless and PacketCable networks, and voice call continuity application servers for continuity of services in IP multimedia subsystem networks. The company offers its services to cable system operators. Arris Group, Inc. was founded in 1969 and is headquarter ed in Suwanee, Georgia.

Advisors' Opinion:

• [By Lee Jackson]

  Arris Enterprises Inc. (NASDAQ: ARRS) got hit when press reports indicated that Apple may be working with Time Warner Cable and other companies on a new set-top box. The Jefferies team do not know the specifications of the device. It still may use “HDMI pass through” architecture like XBox One (and therefore will still require a cable STB to support cable content). That would bode well for Arris. The Jefferies target is lifted to $30. The Thomson/First Call estimate is $28.05. Arris closed on Friday at $27.87.

• [By Rich Smith]

  Suwanee, Ga.-based Arris Group (NASDAQ: ARRS  ) is clear to buy Google's (NASDAQ: GOOG  ) Motorola Home cable set-top box division, the company announced Friday.

Best Rising Stocks To Buy Right Now: Airgas Inc.(ARG)

Airgas, Inc., through its subsidiaries, distributes industrial, medical, and specialty gases, as well as hardgoods in the United States. The company offers various gases, including nitrogen, oxygen, argon, helium, and hydrogen; welding and fuel gases, such as acetylene, propylene, and propane; and carbon dioxide, nitrous oxide, ultra high purity grades, special application blends, and process chemicals. Its hardgoods products comprise welding consumables and equipment, safety products, and construction supplies, as well as maintenance, repair, and operating supplies. The company also engages in the rental of gas cylinders, cryogenic liquid containers, bulk storage tanks, tube trailers, and welding and welding related equipment. In addition, the company manufactures and distributes liquid carbon dioxide, dry ice, nitrous oxide, ammonia, refrigerant gases, and atmospheric merchant gases. It serves repair and maintenance, industrial manufacturing, energy and infrastructure co nstruction, medical, petrochemical, food and beverage, retail and wholesale, analytical, utilities, and transportation industries. The company operates an integrated network of approximately 1100 locations, including branches, retail stores, packaged gas fill plants, specialty gas labs, production facilities, and distribution centers. Additionally, it provides retail solutions to retail customers, such as florists, grocers, restaurants and bars, tire and automotive service centers, and others. The company markets its products through multiple sales channels, including branch-based sales representatives, retail stores, strategic customer account programs, telesales, catalogs, e-business, and independent distributors. Airgas, Inc. was founded in 1982 and is based in Radnor, Pennsylvania.

Advisors' Opinion:

• [By Ben Levisohn]

  The one problem: Air Products & Chemicals valuation. “[Air Products & Chemicals] has generally been at a discount to [Praxair] in the last five years due to its mix and more volatile performance, but closed the gap last year on activist involvement and potential restructuring,” Yang and Amadeo note.�Air Products & Chemicals trades at 21 times 2015 earnings, in line with Airgas’s (ARG) P/E ratio of 21.5 but well above Praxair’s 18.5 times.

Best Rising Stocks To Buy Right Now: Trovagene Inc (TROV)

TrovaGene, Inc. (TrovaGene), incorporated on April 26, 2002, is a development-stage molecular diagnostic company that focuses on the development and marketing of urine-based nucleic acid tests for patient/disease screening and monitoring. The Company's novel tests predominantly use transrenal DNA (Tr-DNA) and transrenal RNA (Tr-RNA). The Company's technology is used to all transrenal nucleic acids (Tr-NA). The Company�� urine-based test addresses market needs, such as women�� healthcare-fetal medicine-down syndrome, infectious diseases, cancer testing, transplantation, drug development and monitoring of therapeutic outcomes, ultra-sensitive analytical and detection system, technologies for the collection, shipment and storage of urine specimens, and transrenal nucleic acid extraction, and instrumentation/system platform.

On January 18, 2011, the Company entered into an asset purchase agreement pursuant to which the Company acquired a hybridoma able to produce a monoclonal antibody targeting the NPM1 biomarker. On February 8, 2011, the Company entered into a sublicense agreement with MLL Munchner Leukamielabor (MLL). In July, 2011, the Company entered into a sublicense agreement with Fairview Health Services (Fairview) for NPM1 patent rights.

In October 2011, the Company entered into a license agreement pursuant to which the Company licensed the patent rights to a specific gene mutation with respect to chronic lymphoblastic leukemia. On December 12, 2011, the Company entered into a license agreement pursuant to which the Company licensed the patent rights to hairy cell leukemia biomarkers. On February 1, 2012, the Company acquired the clinical laboratory improvement amendments (CLIA) laboratory assets of MultiGEN Diagnostics, Inc. (MultiGEN).

Advisors' Opinion:

• [By David Goodboy]

  Fortunately, diagnostic issues may soon be a thing of the past. Several publicly traded companies are currently making great strides in the field of medical diagnostics, and my favorite company right now in that arena is TrovaGene (Nasdaq: TROV).

• [By Daniel Lauchheimer]

  In the past few weeks, I wrote two articles about TrovaGene (TROV) -- one detailing the history of the DNA market generally and the molecular diagnostics -- and TROV's place therein -- market specifically, and the second detailing the company's internal valuation. In this article, I will value TROV on an external, relative basis. Specifically, I will compare TROV to another molecular diagnostics company, Exact Sciences (EXAS), and try to show that while the market seems to have given EXAS a fair shake, it has not done the same for TROV. I will prove this argument by looking at both companies' addressable markets, and their respective progress at bringing the products to market. However, before we take this deep dive into both companies, I will take a moment to review each of the companies' products, so we have a strong background before turning to the deeper analysis.

• [By Roberto Pedone]

  TrovaGene (TROV) is a development stage molecular diagnostic company focused on the development and marketing of urine-based nucleic acid tests for patient/disease screening and monitoring. This stock closed up 6% to $10.02 in Friday's trading session.

  Friday's Volume: 712,000
  
  Three-Month Average Volume: 183,106
  
  Volume % Change: 294%

  From a technical perspective, TROV ripped higher here into all-time high territory with heavy upside volume. This stock has been uptrending strong for the last month and change, with shares soaring higher from its low of $5.75 to its new all-time high of $10.20. During that move, shares of TROV have been making mostly higher lows and higher highs, which is bullish technical price action. That move has also been accompanied by bullish upside volume flows.

  Traders should now look for long-biased trades in TROV as long as it's trending above its recent breakout level of $8.83, and then once it sustains a move or close above its all-time high of $10.20 with volume that hits near or above 183,106 shares. If we get that move soon, then TROV will set up to enter new all-time high territory, which is bullish technical price action. Some possible upside targets off that move are $13 to $15.